North Growth Management Ltd. Acquires 7,000 Shares of Integer Holdings Co. (NYSE:ITGR)

North Growth Management Ltd. boosted its holdings in Integer Holdings Co. (NYSE:ITGR - Free Report) by 7.6% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 99,000 shares of the medical equipment provider's stock after buying an additional 7,000 shares during the quarter. Integer accounts for about 2.4% of North Growth Management Ltd.'s investment portfolio, making the stock its 13th largest position. North Growth Management Ltd. owned approximately 0.30% of Integer worth $12,857,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently modified their holdings of the company. Contravisory Investment Management Inc. raised its holdings in shares of Integer by 55.9% during the third quarter. Contravisory Investment Management Inc. now owns 223 shares of the medical equipment provider's stock worth $29,000 after acquiring an additional 80 shares in the last quarter. Quest Partners LLC increased its holdings in Integer by 3,688.9% in the second quarter. Quest Partners LLC now owns 341 shares of the medical equipment provider's stock worth $39,000 after buying an additional 332 shares during the last quarter. GAMMA Investing LLC raised its position in Integer by 60.9% during the second quarter. GAMMA Investing LLC now owns 375 shares of the medical equipment provider's stock valued at $43,000 after acquiring an additional 142 shares in the last quarter. Headlands Technologies LLC acquired a new stake in Integer in the first quarter valued at approximately $106,000. Finally, Innealta Capital LLC bought a new stake in Integer in the second quarter worth approximately $110,000. Institutional investors and hedge funds own 99.29% of the company's stock.

Analysts Set New Price Targets

ITGR has been the topic of several analyst reports. Oppenheimer started coverage on shares of Integer in a research report on Tuesday, July 16th. They set an "outperform" rating and a $135.00 target price on the stock. Truist Financial cut their price objective on Integer from $150.00 to $147.00 and set a "buy" rating on the stock in a research note on Friday, October 25th. Benchmark boosted their target price on Integer from $130.00 to $140.00 and gave the stock a "buy" rating in a report on Monday, October 21st. KeyCorp lifted their price target on shares of Integer from $139.00 to $144.00 and gave the company an "overweight" rating in a research report on Tuesday, October 15th. Finally, Citigroup upped their price objective on shares of Integer from $124.00 to $130.00 and gave the stock a "neutral" rating in a report on Tuesday, October 1st. One investment analyst has rated the stock with a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $139.75.

Integer Stock Performance

Shares of ITGR traded down $1.01 during trading hours on Tuesday, reaching $138.48. 42,921 shares of the company traded hands, compared to its average volume of 310,417. Integer Holdings Co. has a 1-year low of $84.75 and a 1-year high of $140.91. The stock has a market cap of $4.64 billion, a P/E ratio of 43.09, a price-to-earnings-growth ratio of 1.96 and a beta of 1.09. The stock's fifty day moving average is $128.63 and its 200 day moving average is $122.07. The company has a debt-to-equity ratio of 0.67, a quick ratio of 2.09 and a current ratio of 3.28.

Integer (NYSE:ITGR - Get Free Report) last released its quarterly earnings data on Thursday, October 24th. The medical equipment provider reported $1.43 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.36 by $0.07. Integer had a return on equity of 11.63% and a net margin of 6.70%. The business had revenue of $431.42 million for the quarter, compared to analysts' expectations of $440.59 million. Integer's quarterly revenue was up 8.7% on a year-over-year basis. During the same period in the previous year, the business posted $1.27 earnings per share. Equities research analysts anticipate that Integer Holdings Co. will post 5.33 earnings per share for the current fiscal year.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.